Planquette B, Ferré A, Bédos J-P
Service de réanimation médicochirurgicale, centre hospitalier de Versailles, site Mignot, 177, rue de Versailles, F-78150 Le Chesnay, France.
Reanimation. 2013;22(1):3-13. doi: 10.1007/s13546-012-0634-y. Epub 2013 Mar 13.
Usually, intensivists do not focus on atypical bacteria and viruses in severe community-acquired pneumonia (CAP). Only and virus, following the recent H1N1 influenza pandemic, are routinely suggested as responsible agents. However, CAP due to atypical bacteria may represent up to 44% of all CAP. Viral CAP is considered less severe than the usual bacterial ones, although 25% of them warrant hospitalization and 15% result in severe sepsis. Even though is the most frequently atypical pathogen involved in severe cases, may be responsible for multiorgan failure. To date, tools including detection of in urine and using polymerase chain reaction (PCR) allow rapid and accurate diagnosis. The treatment is based on macrolides and fluoroquinolones that can be associated in severe Legionnaire diseases. The presence of virus in CAP, either alone or in association with bacteria, has been demonstrated using molecular biology tests. These techniques also allowed the identification of several new viruses in CAP. However, the exact role of these detected viruses in CAP as well as the efficiency of antiviral therapy still represent major unsolved concerns.
通常,重症监护医生在严重社区获得性肺炎(CAP)中并不关注非典型细菌和病毒。在近期甲型H1N1流感大流行之后,只有 和 病毒被常规认为是致病原。然而,由非典型细菌引起的CAP可能占所有CAP的44%。病毒性CAP被认为比常见细菌性CAP病情较轻,尽管其中25%需要住院治疗,15%会导致严重脓毒症。尽管 是严重病例中最常涉及的非典型病原体,但 可能导致多器官功能衰竭。迄今为止,包括尿液中 检测和使用聚合酶链反应(PCR)检测 在内的工具可实现快速准确的诊断。治疗基于大环内酯类和氟喹诺酮类药物,在严重军团病中可联合使用。通过分子生物学检测已证实CAP中病毒单独或与细菌并存的情况。这些技术还使人们能够识别出CAP中的几种新病毒。然而,这些检测到的病毒在CAP中的确切作用以及抗病毒治疗的效果仍然是主要未解决的问题。